Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Correspondence

Obstructive Uropathy as an Initial Presentation of Primary Myelofibrosis: Case Report and Review of Literature

Authors: Anirban Ganguli, Ramandeep Singh Chalokia, Brahm Jyot Kaur

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

Primary myelofibrosis (PMF) is a rare hematological disorder associated with progressive cytopenia and extra-medullary hematopoiesis. Acute kidney injury in this disease has been reported from diverse etiologies such as renal and peri-renal extramedullary hematopoiesis and tumor lysis syndrome. We report a patient who presented with obstructive uropathy from uric acid stones who was incidentally diagnosed with PMF during workup for persistent thrombocytosis and leukocytosis. Marrow histopathology was unique in presenting features of early PMF despite clinical picture mimicking essential thrombocythemia. Despite a common background of hyperuricemia in myeloproliferative neoplasms, AKI resulting from urate nephrolithiasis has seldom been reported in PMF. Published data on this association and clinical management is reviewed briefly.
Literature
1.
go back to reference James W, Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951CrossRef James W, Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951CrossRef
2.
go back to reference Tefferi A, Pardanani A (2015) Myeloproliferative neoplasms: a contemporary review. JAMA Oncol. 1(1):97–105CrossRefPubMed Tefferi A, Pardanani A (2015) Myeloproliferative neoplasms: a contemporary review. JAMA Oncol. 1(1):97–105CrossRefPubMed
3.
go back to reference Geyer HL, Mesa RA (2014) Therapy for myeloproliferative neoplasms: when, which agent, and how? Blood 124:3529–3537CrossRefPubMed Geyer HL, Mesa RA (2014) Therapy for myeloproliferative neoplasms: when, which agent, and how? Blood 124:3529–3537CrossRefPubMed
4.
go back to reference Woodward N, Ancliffe P, Griffiths MH et al (2000) Renal myelofibrosis: an usual case of renal impairment. Nephrol Dial Transplant 15:257–258CrossRefPubMed Woodward N, Ancliffe P, Griffiths MH et al (2000) Renal myelofibrosis: an usual case of renal impairment. Nephrol Dial Transplant 15:257–258CrossRefPubMed
5.
go back to reference Sile S, Wall BM (2001) Acute renal failure secondary to spontaneous acute tumor lysis syndrome in myelofibrosis. Am J Kidney Dis 38(4):E21CrossRefPubMed Sile S, Wall BM (2001) Acute renal failure secondary to spontaneous acute tumor lysis syndrome in myelofibrosis. Am J Kidney Dis 38(4):E21CrossRefPubMed
7.
go back to reference Oesterling JE1, Keating JP, Leroy AJ et al (1992) Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladder. J Urol 147(5):1360–1362 Oesterling JE1, Keating JP, Leroy AJ et al (1992) Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladder. J Urol 147(5):1360–1362
8.
9.
10.
go back to reference Ganguli A, Sawinski D, Berns JS (2015) Kidney diseases associated with haematological cancers. Nat Rev Nephrol 11:478–490CrossRefPubMed Ganguli A, Sawinski D, Berns JS (2015) Kidney diseases associated with haematological cancers. Nat Rev Nephrol 11:478–490CrossRefPubMed
Metadata
Title
Obstructive Uropathy as an Initial Presentation of Primary Myelofibrosis: Case Report and Review of Literature
Authors
Anirban Ganguli
Ramandeep Singh Chalokia
Brahm Jyot Kaur
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-016-0679-6

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine